Stay updated with breaking news from Hematologic Malignancies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers estimate that, for every 10,000 children who undergo a CT scan today, 1.4 will develop a hematologic malignancy in the next 12 years. Researchers estimate that, for every 10,000 children who undergo a CT scan today, 1.4 will develop a hematologic malignancy in the next 12 years.
Mark Leick, MD, discusses how the emergence of CAR T-cell therapies have affected the treatment paradigms in various hematologic malignancies, expands on how persisting challenges with the use of this type of treatment are being addressed, and details research into the use of CAR T-cell therapy in patients with solid tumors.
Marisol Miranda-Galvis, DDS, MS, PhD, highlights the importance of understanding which social determinants of health have the greatest influence on treatment-related outcomes in patients with hematologic malignancies, expands on key variables identified in a systematic review of these disparities, and emphasizes the importance of continuing to implement new strategies to increase access to quality treatments.
Panelists explore recent findings of the PATHFINDER study, focusing on the objectives, study design, key results, and differences from previous studies, shedding light on the potential of early cancer detection tests.
(2023-10-16 | NDAQ:IPHA) Innate Pharma Announces Abstracts Selected for ESMO Congress 2023